News

Ondo Guber: Coalition Rates Chances Of APC Aspirants

Published

12 months ago

March 23, 2024

By Uche Onyeali

Coalition of supporters of the All Progressives Congress, under of APC Support Groups, has rated the chances of the aspirants for the party ticket in the November 21, 2024, Ondo State governorship election.

In an opinion poll conducted by the APC support group, Wale Akinterinwa scored 89 percent to emerge favourite to clinch the ticket of the ruling party.

The survey result signed by the national coordinator of the coalition, Dr. Muhammed Joda, and the national secretary, Comrade Kingsley Ebhoma, Olusola Oke is tipped to come second in the race with 65 percent while Senator Jimoh Ibrahim comes third with 35 percent.

According to the survey, the incumbent governor, Hon. Lucky Aiyedatiwa has 25 percent chances to remain in office while Paul Akinyelure trails far behind with five percent, as the result indicated that he and some others lack significant support, “with participants deeming them unfit to lead the state at present.”

Speaking on the outcome of the poll, the coalition noted that “as support groups of the party, we are duty-bound to also ensure peace, unity and progress in the party at all levels, while promoting the activities/good governance. Hence our embarking on an independent opinion poll exercise, survey and assessment of the potential aspirant for the party’s ticket ahead of the party’s primary election as to avoid a repeat of the incidence that played out in Edo State where the party was almost being ridiculed for not conducting a transparent, free, fair and open all-inclusive primary elections.

It is evident that Olusola Oke, Jimoh Ibrahim, Wale Akinteriwa, Lucky Aiyedatiwa, Paul Akintelure, stands tall among other aspirants for the party’s ticket.

“However, this report presents findings from a survey conducted to assess potential candidates for the APC Party Primaries in April, with a focus on their ability to sustain continuity in governance – protect the legacies of AKETI.

The survey aimed to gauge public perception and support for various aspirants based on their track records, political knowledge and alignment with AKETI’s mission and vision for the state.

“Utilising a total of 3,600 individuals, with 200 sample, from the Local Government Areas through random sampling of the voters’ register, this survey provides a comprehensive understanding of voters’ sentiments across diverse geographic regions within the state.”

Share on Facebook

News

NICRAT, Roche, Oncopadi launch BRANT app for breast cancer care

Published

4 days ago

March 13, 2025

The Gleamer

NICRAT, Roche, and Oncopadi unveiled the Breast Cancer Access Navigation and Testing (BRANT) application on Thursday in Abuja, aimed at reshaping breast cancer diagnosis and treatment in Nigeria.

At the launch, Prof. Usman Aliyu, Director-General of the National Institute for Cancer Research and Treatment (NICRAT), described BRANT as a significant step in the country’s efforts to enhance patient care and streamline support systems.

He emphasised that the app would also empower individuals battling breast cancer, offering them better access to resources and guidance throughout their journey.

Represented by Dr Waziri Usman, the Director of Cancer Prevention and Control, Aliyu emphasised that breast cancer remained one of the most prevalent and deadly forms of cancer among Nigerian women.

He noted that early detection, timely intervention, and leveraging technology could greatly improve diagnosis and treatment outcomes.

BRANT, he explained, was designed to make navigating the complex landscape of breast cancer diagnosis and treatment easier, by connecting patients, healthcare providers, support groups, NGOs, and civil society organisations into one unified system.

Dr Omolola Salako, CEO of Oncopadi, highlighted the shortage of oncologists in Nigeria, with fewer than 95 oncologists nationwide, particularly in rural areas.

She stressed the need for technology to bridge the gap, allowing oncologists to reach patients across the country.

“Oncopadi has already been mobilising cancer patients for online care and educational resources over the past seven years.

“In partnership with Roche, Oncopadi is supporting 5,000 women newly diagnosed with breast cancer.

“The collaboration leverages Roche’s expertise in oncology diagnostics and Oncopadi’s digital oncology capabilities to launch BRANT.”

Dr Ladi Hameed, General Manager of Roche Products Limited, emphasised the organisation’s commitment to address the growing burden of breast cancer through awareness, early detection, and access to treatment.

“The BRANT programme, which includes free immunohistochemistry testing and multidisciplinary teams, aims to remove financial barriers that delay diagnoses and treatment,”he said.

While the programme would run for the next 18 months, Hameed called for collective efforts to ensure its sustainability.

Mr Alexander Chimbaru, Deputy Country Representative of the World Health Organisation (WHO) to Nigeria, lauded the initiative, calling it a valuable solution to reduce the burden of breast cancer.

He stressed the importance of taking action to ensure the programme’s success.

Dr Fatima Kyari, Registrar of the Medical and Dental Council of Nigeria (MDCN), supported the initiative, urging the organisations to adhere to regulatory guidelines regarding specialist support, digital health tools, and patient information.

The News Agency of Nigeria (NAN) reports BRANT is a user-friendly platform offering personalised care, expert consultations, diagnostic tests, treatment facilities, and support for patients throughout their breast cancer journey.

NAN

Share on Facebook